Abstract
Antithrombin 3 and plasminogen were measured in 33 women taking oral contraceptives in 33 women in the third trimester of pregnancy and in 19 control women. Antithrombin determined by a modification of the von KAULLA method was a mean of 30.2 seconds in controls 19.4 seconds in pill users and 19.6 seconds in pregnant women. Plasminogen determined by a modification of SWAIMs method was a mean 98.5% in controls 166.5% in pill users 152.8% in pregnant women and 185.9% in a group of 18 users of Ovulen (1 mg ethynodiol and .1 mg mestranol combined) who were treated for neurologic symptoms such as headaches dizziness or cerebrovascular accidents. All the experimental means differed significantly from the controls (p<.1%).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
